全球预立指示（AD）市场（~2028）：组成部分（软体/服务）、结构（老年人、中年、年轻）、最终用户（B2B（医疗保健提供者、保险公司）、B2C）・按地区

预设医疗指示 (AD) 市场规模预计将从 2023 年的 1,229 亿美元增长到 2028 年的 2,911 亿美元，预测期内年复合成长率为 18.8%。

预测在预测期内，对AD的投资增加以及政府旨在加强患者护理和自主权的倡议和法律规章将为市场提供有利的机会。

从组成部分来看，到 2022 年，部门将占很大比例。人们越来越认识到预立医疗照护计画的重要性，以及卫生政策和法律规章对 AD 在减少不必要的干预和医疗费用以及确保以病人为中心的照护方面的好处的认识。它已经成为。这种认识促使卫生系统将这些服务整合标准实践，推动该部门的快速成长。

此外，从最终用户来看，医疗保健提供者部门在 2022 年也占据了相当大的份额。由于医疗保健系统优先考虑以患者为中心的护理和个体化治疗，因此医疗保健提供者在发起有关末期病人的意图、治疗选择和医疗干预措施的对话方面发挥关键作用。提供者的专业知识以及与患者的信任关係对于有效引导有关预先护理计划的敏感讨论至关重要。此外，医疗保健提供者采用电子健康记录(EHR) 和数数位工具正在简化 AD 的记录和普及，使患者的偏好更容易获取和执行。

从地区来看，亚洲预计在预测期内将呈现显着的成长率。由于反映社会意识不断发展、医疗保健机会增加以及患者自主意识不断增强等要素的综合作用，预计亚洲市场在预测期内将以较高的年复合成长率增长。在该地区，由于高龄化和慢性病增加等人口变化，人们对临终关怀重要性的认识不断提高。各国政府和医疗保健组织正在努力克服围绕死亡和临终关怀讨论的文化禁忌，并促进更公开的对话。此外，医疗保健基础设施的进步和以患者为中心的护理倡议的兴起使 AD 资源更容易获得。患者希望在医疗决策中拥有发言权，再加上使医疗保健与个人偏好保持一致的配合措施，正在推动亚洲的显着增长。

该报告调查了全球预先指示（AD）市场，并提供市场概述、市场影响因素和市场机会分析、技术趋势、案例研究、法律制度、市场规模趋势和预测以及各种细分。・编制详细的区域分析、竞争形势、主要企业简介等。

目录

第1章简介

第2章调查方法

第3章执行摘要

第4章重要考察

第5章市场概况

• 市场动态
  • 促进因素
  • 机会
  • 任务
• 产业趋势
  • ACP 的数位转型
  • 资料驱动的见解：转变 ACP
  • 加强 ACP 中的患者参与和个体化护理
• 技术分析
• 波特五力分析
• 法规状况
• 价值链分析
• 生态系/市场地图
• 专利分析
• 邻近市场分析
• 案例研究分析
• 主要利害关係人和采购标准
• 重大会议及活动
• 影响买家的趋势/颠覆

第6章预立指示 (AD) 市场：依组成部分

• 软体
• 服务

第7章预立指示 (AD) 市场：依结构

• 老年组
• 中年
• 年轻人

第8章预立指示 (AD) 市场：依最终使用者分类

• B2B
• B2C

第9章预立指示 (AD) 市场：依地区

• 北美洲
• 欧洲
• 亚太地区
• 其他地区

第10章竞争形势

• 主要企业/龙头企业策略
• 市场排名分析
• 企业评价矩阵
• 竞争基准化分析
• 主要企业分析
• 竞争格局及趋势

第11章公司简介

• 主要企业
  • ADVAULT, INC.
  • VYNCACARE
  • WISERCARE, INC.
  • IRIS
  • KODA HEALTH
  • THOROUGHCARE, INC.
  • VITAL DECISIONS LLC
  • AFFIRM HEALTH, INC.
  • MIDEO
  • NEW CENTURY HEALTH
  • THANACARE
  • HONOR MY DECISIONS LLC
• NPO
  • SHARP HEALTHCARE
  • ACP DECISIONS
  • BRONSON HEALTHCARE
  • ISLAND HEALTH
  • MUNSON HEALTHCARE

第12章附录

The advance directives market is projected to reach USD 291.1 billion by 2028 from USD 122.9 billion in 2023, at a CAGR of 18.8% during the forecast period. The rising inestments in advance directives and government initiatives and regulations to enhance patient care and autonomy will provide lucrative opportunities to the market during the forecast period.

"Advance directives services segment accounted for a substantial share of the advance directives market, by component in 2022."

In 2022, the advance directives services segment accounted for a substantial share of the advance directives market. Rising awareness of the importance of proactive healthcare planning, healthcare policies and regulations are increasingly recognizing the benefits of advance directives in terms of reducing unwanted interventions, healthcare costs, and ensuring patient-centered care. This recognition has led healthcare systems to integrate these services into their standard practices, driving the segment's rapid growth.

"Healthcare Providers segment accounted for a considerable share in the advance directives market, by end user in 2022"

In 2022, the healthcare providers segment accounted for a significant share of the advance directives market. As healthcare systems prioritize patient-centered care and personalized treatment, providers play a key role in initiating conversations about end-of-life preferences, treatment options, and medical interventions. Their expertise and trusted relationships with patients position them to effectively navigate sensitive discussions surrounding advance care planning. Moreover, healthcare providers' adoption of electronic health records (EHRs) and digital tools has streamlined the documentation and dissemination of AD documents, enhancing the accessibility and implementation of patient wishes. As a result, the healthcare providers segment stands as a prominent driver of growth within the advance directives market.

"Asia to witness the substantial growth rate during the forecast period."

The Asian market is projected to grow at the high CAGR during the forecast period due to a confluence of factors that reflect evolving societal attitudes, increased healthcare access, and a growing awareness of patient autonomy. As the region undergoes demographic shifts, including an aging population and an increase in chronic diseases, there is a heightened recognition of the importance of end-of-life planning. Governments and healthcare organizations are working to overcome cultural taboos surrounding discussions of death and end-of-life care, fostering a more open dialogue. Additionally, advancements in healthcare infrastructure and a rise in patient-centered care initiatives are facilitating greater access to AD resources. The desire for patients to have a say in their medical decisions, coupled with efforts to align medical care with individual preferences, is propelling the substantial growth of AD in Asia's forecasted years.

The break-down of primary participants is as mentioned below:

• By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
• By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

Key Players in the Advance directives Solutions Market

The key players operating in the advance directives market include ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US), Bronson Health Care Group, Inc. (US), Koda Health(US), ThroughCare, Inc.(US), Vital Decisions LLC (US), Affirm Health Inc. (US), MIDEO(US), New Century Health (US), Thanacare(US), Island Health(Canada), Honor My Decisions LLC (US).

Research Coverage:

The report analyzes the Advance directives Market and aims to estimate the market size and future growth potential of various market segments, based on components, demographics , end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (increasing Investments in advance directives in developed as well as emerging technology adoption, rising demand for personalized care, increasing funding and investments in advance care planning, restraints (lack of awareness and education, communication barrier, opportunities (technological advancement and digital solutions, policy support and legislative framework), and challenges (fragmented healthcare system and lack of indiciplinary collaboration and commiunication) influencing the growth of the advance directives market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the advance directives market.
• Market Development: Comprehensive information on the lucrative emerging markets, component, demographics , end-user, and region.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the advance directives market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the advance directives market like ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US) etc.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH METHODOLOGY STEPS
  • 2.2.1 SECONDARY DATA
    • 2.2.1.1 SECONDARY SOURCES
  • 2.2.2 PRIMARY DATA
    • 2.2.2.1 PRIMARY SOURCES
    • 2.2.2.2 KEY INSIGHTS FROM PRIMARY SOURCES
• 2.3 MARKET SIZE ESTIMATION
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.5 ASSUMPTIONS FOR THE STUDY
• 2.6 LIMITATIONS
• 2.7 RISK ASSESSMENT
• 2.8 RECESSION IMPACT ON THE ADVANCE DIRECTIVESMARKET

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • DRIVERS
  • RESTRAINTS
  • OPPORTUNITIES
  • CHALLENGES

6 INDUSTRY INSIGHTS

• 6.1 INTRODUCTION
• 6.2 INDUSTRY TRENDS
• 6.3 TECHNOLOGY ANALYSIS
• 6.4 PORTERS FIVE FORCES ANALYSIS
• 6.5 REGULATORY ANALYSIS
  • NORTH AMERICA
  • EUROPE
  • ASIA PACIFIC
• 6.6 VALUE CHAIN ANALYSIS
• 6.7 ECOSYSTEM ANALYSIS
• 6.8 PRICING ANALYSIS
• 6.9 PATENT ANALYSIS
• 6.10 ADJACENT MARKET ANALYSIS
• 6.11 CASE STUDY ANALYSIS
• 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
• 6.13 KEY CONFERENCES AND EVENTS, 2023–2024
• 6.14 TRENDS/DISRUPTIONS IMPACTING BUYERS

7 ADVANCE DIRECTIVES MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 SOFTWARE
• 7.3SERVICES

8 ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS/AGE

• 8.1 INTRODUCTION
• 8.2 ELDERLY POPULATION (65 YEARS AND ABOVE)
• 8.3 MIDDLE-AGED ADULTS (40-64 YEARS)
• 8.4 YOUNG ADULTS (18-39 YEARS)

9 ADVANCE DIRECTIVES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 B2B CONSUMER
  • HEALTHCARE PROVIDERS
  • PAYERS
• 9.3 B2C CONSUMERS
• 9.4 OTHER END USERS

10 ADVANCE DIRECTIVES MARKET, BY REGION

• INTRODUCTION
• NORTH AMERICA
  • US
  • CANADA
• EUROPE
  • GERMANY
  • UK
  • REST OF EUROPE
• ASIA PACIFIC
  • CHINA
  • JAPAN
  • REST OF ASIA PACIFIC
• REST OF THE WORLD

11 COMPETITIVE LANDSCAPES

• OVERVIEW
• STRATEGIES ADOPTED BY KEY PLAYERS
• MARKET RANKING/SHARE ANALYSIS
• COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
• COMPANY FOOTPRINT OF PLAYERS IN ADVANCE DIRECTIVES MARKET
• COMPETITIVE SCENARIO

12 COMPANY PROFILES

• COMPANY PROFILES
  • ADVAULT, INC.
  • VYNCA INC.
  • WISERCARE
  • SHARP HEALTHCARE
  • ACP DECISION (A DBA OF NOUS FOUNDATION, INC.)
  • IRIS (ALEDADE)
  • BRONSON HEALTHCARE
  • KODA HEALTH
  • THOROUGHCARE-
  • VITAL DECISIONS LLC
  • AFFIRM HEALTH
  • MIDEO
  • NEW CENTURY HEALTH
  • VITAS HEALTHCARE
  • THANACARE
  • ISLAND HEALTH
  • HONOR MY DECISIONS

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
• 13.3 AVAILABLE CUSTOMIZATIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS